rxstatShortages › Esomeprazole

Esomeprazole (Nexium -) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 29, 2026

Some Esomeprazole products are in shortage in Canada (11 of 26 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 10, 2027.

A proton pump inhibitor used to reduce stomach acid in conditions such as acid reflux and ulcers.

Products affected
11 / 26
In shortage since
Apr 23, 2025
Est. full return
Oct 10, 2027
Reports on file
122
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
ESOMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02520699 · since Mar 12, 2026, est. end Aug 14, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-ESOMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · APOTEX INC
DIN 02339099 · since May 12, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · APOTEX INC
DIN 02339102 · since May 19, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
SANDOZ ESOMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02460920 · since Jun 15, 2026, est. end Jul 20, 2026 · Delay in shipping of the drug.
Active shortage
PMSC-ESOMEPRAZOLE DR
20MG · TABLET (DELAYED-RELEASE) · PHARMASCIENCE INC
DIN 02528479 · since Nov 12, 2025, est. end Oct 10, 2027 · Disruption of the manufacture of the drug.
Active shortage
PMSC-ESOMEPRAZOLE DR
40MG · TABLET (DELAYED-RELEASE) · PHARMASCIENCE INC
DIN 02528487 · since Oct 29, 2025, est. end Oct 10, 2027 · Disruption of the manufacture of the drug.
Active shortage
MYL-ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02479427 · since Oct 17, 2025, est. end Oct 27, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · APOTEX INC
DIN 02339102 · since Jan 6, 2026, est. end Apr 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · SANIS HEALTH INC
DIN 02431173 · since Aug 11, 2025, est. end Oct 9, 2026 · Disruption of the manufacture of the drug.
Active shortage
ESOMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · SANIS HEALTH INC
DIN 02535335 · since Aug 11, 2025, est. end Oct 9, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02423863 · since Aug 19, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02423863 · since Apr 23, 2025, no end estimate · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Esomeprazole is currently affected by 11 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, APOTEX INC, SANDOZ CANADA INCORPORATED, PHARMASCIENCE INC and 3 others.

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Esomeprazole is classified under “DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)” (ATC A02BC).

Recent changes

Common questions

What is Esomeprazole used for?

A proton pump inhibitor used to reduce stomach acid in conditions such as acid reflux and ulcers.

When will Esomeprazole be back in stock in Canada?

The latest manufacturer estimate is Oct 10, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Esomeprazole in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (drugs for peptic ulcer and gastroesophageal reflux disease (gerd))

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.